Eli Lilly Brings New, Cheaper Insulin to the United States

News in the past few years have not been positive about diabetes patients in the United States – the price of the medicine they need has been following a sad, upward trend. Thankfully, there might be some cheaper salvation for them – Eli Lilly is adding a new half-priced insulin brand to their portfolio.


The new product titled ‘Lispro’ is set to sell for $137 for vial – almost twice as well than the Eli Lilly’s original insulin injection, the Humalog. However, this raises some concerns regarding the quality of the product, and whether it will be nearly as good and effective as the brand-name version – however, the Food and Drug Administration (FDA) confirms that generic drugs are identical to the brand name ones. The company’s statement confirms that Lispro is suitable for both type 1 and type 2 diabetes treatment.


Generic medicines are common in the United States, but insulin shots were not among them until now. Experts believe that the introduction of a generic-brand insulin shot might be a step in the right direction when it comes to controlling medication prices. In addition to this, it should substantially help those diabetes patients who do not purchase insulin via their health insurance benefits.

Source: https://www.healthline.com/health-news/who-will-benefit-from-eli-lillys-new-cheaper-insulin